Public Health & Associations -- MEDICA Trade Fair

Image: Comparison of normal vs hepatoblastoma liver tissue; Copyright: Etienne Meylan/EPFL

Metabolism can be used to subtype hepatoblastoma tumors

19/09/2017

Looking at cell metabolism instead of histology, EPFL scientists have identified new biomarkers that could help more accurately classify the two main subtypes of hepatoblastoma, a children liver cancer. Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life.
Read more
Image: liver with a warning sign on it; copyright: panthermedia.net/Sebastian Kaulitzki

How liver cancer develops

13/09/2017

Liver cancer is the second-leading cause of cancer-related death and represents the fastest rising cancer worldwide. In most cases, the tumor develops in patients with chronic liver disease. Such diseases include chronic infections with hepatitis viruses or a so-called fatty liver due to nutritional or genetically caused lipometabolic disorders or an excessive consumption of alcohol.
Read more
Image: Diagram of the research results; Copyright: Osaka University

New drug targets for a rare kidney and liver disease

07/09/2017

In a joint international study, researchers from Osaka University have partnered with research groups from the United States and Spain to uncover how mutations in a single gene called PKHD1 lead to symptoms associated with a rare kidney and liver disease, ARPKD (autosomal recessive polycystic kidney disease).
Read more
Image: illustration of co‐expression networks; Copyright: KTH Royal Institute of Technology

Study offers new targets for drugs to treat fatty liver disease and liver cancer

23/08/2017

There may be no silver bullet for treating liver cancer or fatty liver disease, but knowing the right targets will help science develop the most effective treatments. Researchers in Sweden have just identified a number of drug targets that can be used in the development of new efficient treatment strategies with minimum side effects.
Read more
Image: illustration of the immune system; Copyright: panthermedia.net/ralwel

New test for rare immunodeficiency

23/08/2017

Researchers at the University of Basel have developed a test to quickly and reliably diagnose a rare and severe immune defect, hepatic veno-occlusive disease with immunodeficiency. They reported on their findings in the "Journal of Clinical Immunology".
Read more